List of the latest marketing authorisations and orphan medicinal products designations

Detailed information on European orphan medicinal products designation applications is available on the EMA website. A full list of designated and authorised orphan medicinal products in Europe available at: ec.europa.eu.

Learn more about the Orphan designation process in Europe

Recent marketing authorisations

See a list of orphan medicines currently authorised in the EU.

Medicinal Product	Marketing Authorisation Holder	Therapeutic Indication	Date of Marketing Authorisation
Isturisa® (osilodrostat)	Novartis Europharm Limited	Cushing Syndrome	09/01/2020
Polivy® (polatuzumab vedotin)	Roche Registration GmbH	Diffuse large B-cell lymphoma (DLBCL)	16/01/2020